Neuromuscular AgentsPeripheral Nervous System AgentsPhysiological Effects of DrugsAcetylcholine Release InhibitorsMembrane Transport ModulatorsMolecular Mechanisms of Pharmacological ActionCholinergic AgentsNeurotransmitter AgentsincobotulinumtoxinABotulinum Toxins, Type A
The purpose of this study is to assess the safety and efficacy of NT 201 compared with placebo in participants with mode…
MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.
Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States
Jesse Brown VA Medical Center, Chicago, IL, Chicago, Illinois, United States
Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois, United States
Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois, United States
Rehabilitation R&D Service, Baltimore, MD, Baltimore, Maryland, United States
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts, United States
VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, United States
John D. Dingell VA Medical Center, Detroit, MI, Detroit, Michigan, United States
Asheville VA Medical Center, Asheville, NC, Asheville, North Carolina, United States
Durham VA Medical Center, Durham, NC, Durham, North Carolina, United States
Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio, United States
Oklahoma City VA Medical Center, Oklahoma City, OK, Oklahoma City, Oklahoma, United States
VA Portland Health Care System, Portland, OR, Portland, Oregon, United States
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas, United States
Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States
South Texas Health Care System, San Antonio, TX, San Antonio, Texas, United States
VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States
VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States
Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee, Wisconsin, United States
VA Caribbean Healthcare System, San Juan, PR, San Juan, Puerto Rico
Phase 3
Recruiting
Neuromuscular AgentsPeripheral Nervous System AgentsPhysiological Effects of DrugsAcetylcholine Release InhibitorsMembrane Transport ModulatorsMolecular Mechanisms of Pharmacological ActionCholinergic AgentsNeurotransmitter AgentsincobotulinumtoxinABotulinum Toxins, Type A
The purpose of this study is to assess the safety and efficacy of NT 201 compared with placebo in participants with mode…
Scottsdale, United StatesEst. completion Jun 5, 2026